The 100,000 Genomes Project
Moorfields is one of six trusts participating in the 100,000 genome project which hopes to develop personalised medicine with the aim of treating rare diseases and cancer.
What is a genome?
Your genome is one whole set of your genes, plus all the DNA between your genes. There’s a copy in almost every cell of your body and it’s the instructions for making, running and repairing you.
Genes account for less than 5% of your genome. It used to be thought that the rest of the DNA was junk but now we know all of your genome is important.
The 100,000 Genome Project aims to sequence 100,000 whole genomes from about 70,000 people. Participants are NHS patients with rare diseases plus their families and patients with certain types of cancer.
Sequencing means reading all the 3 billion DNA letters in your genome one by one. Research has shown that every letter counts.
That’s why the 100,000 genomes project is doing whole genome sequencing.
What is Moorfields involvement?
Moorfields is part of the North Thames NHS Genomic Medicine Centre which is made up of six trusts: Barts Health; Great Ormond Street Hospital; the Royal Free London NHS Foundation Trust; North London West Healthcare and University College London Hospital NHS Foundation Trust.
Moorfields treats rare and inherited retinal conditions. It is now recruiting about 100 patients a month as part of its commitment to recruit 2,200 genomes for the project.
About the 100,000 Genomes Project
The 70,000 participants are NHS patients with rare disease plus their families and patients with certain types of cancer.
With their consent their genomes will be sequenced and linked to details about an individual’s medical condition. Doing this may help medical teams provide better diagnosis or treatment - but it may not because not enough is known yet about the meaning of all the genomic data.
By adding key information from medical records and putting all the data in one highly secure place, scientists can compare the data from tens, hundreds or even thousands of people with the same condition. Allowing approved scientists to have monitored access to this data is a very powerful way to understand the causes of ill health and how to treat it.
Aims of the project
Improving care for patients: Some patients with rare disease may get a diagnosis for the first time or discover what treatment might work best.
Setting up an NHS genomic medicine service:
By the time it finishes, this project will have put everything in place to enable the NHS to offer genomic medicine to those patients who need it. Genomic medicine will mean personalised treatment for patients.
For future generations: By looking at all the 100,000 Genomes Project data, scientists will gain new insights and understanding about the causes of disease and find better ways of helping patients, especially those who have conditions that are currently hard to treat.
To kickstart a UK genomics industry: Participants generously agree that researchers from industry such as pharmaceutical companies can look at their data. This is the best and quickest way to ensure that understanding from the project is turned into new medicines and diagnostics for patients. It will also help establish new jobs and companies in this important field in the UK.
Who is involved?
The project is being run by Genomics England, a company wholly owned by the Department of Health. Genomics England is working together with NHS England, Health Education England and Public Health England to deliver the 100,000 Genomes Project. NHS Genomic Medicine Centres (GMCs) have been set up across the country to recruit patients, take the samples and provide medical information to the project.
Who is eligible?
At the moment, patients with certain inherited rare diseases and some common cancers may be able to take part. Patients are referred to their local GMC by their clinical geneticist or hospital consultant. The project is in the early stages.
In the future, it is possible that patients with other conditions, and those in other parts of the country will be able to take part too.
Samantha Lawrence, research coordinator
Genetics Department, Moorfields Eye Hospital, 162 City Road, London EC1V 2PD
Tel: 0207 566 2260
Genomics England , Queen Mary University of London
Dawson Hall, Charterhouse Square, London EC1M 6BQ
Tel: 0207 882 6392
Please see the leaflets on the right hand side of the page for more information.